We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma (VIT-0910)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01355445
Recruitment Status : Recruiting
First Posted : May 18, 2011
Last Update Posted : July 21, 2017
Information provided by (Responsible Party):
Centre Oscar Lambret

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : September 2021